
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $7.4B | $8.5B | $9B | $9.7B | $10.1B | |
Revenue Growth (YoY) | 51.13% | 14.82% | 5.3% | 7.56% | 4.68% | |
Cost of Revenues | $3.7B | $3.8B | $3.8B | $3.7B | $3.8B | |
Gross Profit | $3.8B | $4.8B | $5.2B | $5.9B | $6.3B | |
Gross Profit Margin | 50.82% | 55.73% | 57.9% | 61.39% | 62.79% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9B | $3.4B | $3.5B | $4.1B | $4.3B | |
Other Inc / (Exp) | -- | -- | -$1B | -$136.7M | $273.1M | |
Operating Expenses | $2.9B | $3.4B | $3.5B | $4.1B | $4.3B | |
Operating Income | $894M | $1.4B | $1.7B | $1.9B | $2.1B | |
Net Interest Expenses | $300M | $314.3M | $415.8M | $546.4M | $464.8M | |
EBT. Incl. Unusual Items | $594M | $1B | $224.3M | $1.2B | $1.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $77.2M | $169M | $166.7M | $209M | $295.1M | |
Net Income to Company | $605.1M | $987.9M | $143.3M | $1B | $1.6B | |
Minority Interest in Earnings | -$20.6M | -$22.4M | -$31.8M | -$42.6M | -$73.8M | |
Net Income to Common Excl Extra Items | $584.5M | $965.5M | $111.5M | $986.2M | $1.6B | |
Basic EPS (Cont. Ops) | $1.95 | $3.30 | $0.41 | $3.78 | $6.18 | |
Diluted EPS (Cont. Ops) | $1.95 | $3.29 | $0.40 | $3.77 | $6.16 | |
Weighted Average Basic Share | $299.2M | $292.7M | $275.2M | $261.1M | $254.3M | |
Weighted Average Diluted Share | $300.5M | $293.7M | $275.6M | $261.7M | $254.8M | |
EBITDA | $2.6B | $3.1B | $2.3B | $3.6B | $4.4B | |
EBIT | $937.5M | $1.4B | $673.8M | $1.8B | $2.5B | |
Revenue (Reported) | $7.4B | $8.5B | $9B | $9.7B | $10.1B | |
Operating Income (Reported) | $894M | $1.4B | $1.7B | $1.9B | $2.1B | |
Operating Income (Adjusted) | $937.5M | $1.4B | $673.8M | $1.8B | $2.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2B | $2.2B | $2.3B | $2.4B | $2.4B | |
Revenue Growth (YoY) | 4.54% | 8.35% | 6.32% | 5.57% | -0.33% | |
Cost of Revenues | $925.2M | $957.2M | $947.8M | $922.4M | $921.2M | |
Gross Profit | $1.1B | $1.2B | $1.3B | $1.5B | $1.5B | |
Gross Profit Margin | 53.51% | 55.61% | 58.66% | 61.89% | 61.81% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $789.5M | $823.1M | $1B | $1B | $1B | |
Other Inc / (Exp) | -- | -- | -$244.8M | -- | $4M | |
Operating Expenses | $789.5M | $823.1M | $1B | $1B | $1B | |
Operating Income | $275.3M | $375.9M | $301.6M | $452.3M | $466.9M | |
Net Interest Expenses | $78.9M | $91.6M | $111.8M | $126.2M | $117.7M | |
EBT. Incl. Unusual Items | $196.4M | $284.4M | -$55.1M | $326M | $353.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.7M | $52.2M | -$31.4M | $19.4M | $58.7M | |
Net Income to Company | $198.4M | $249.6M | -$4.4M | $323.1M | $312.8M | |
Minority Interest in Earnings | -$1.7M | -$4.9M | -$6.6M | -$9.8M | -$7M | |
Net Income to Common Excl Extra Items | $196.7M | $244.7M | -$11M | $313.3M | $305.7M | |
Basic EPS (Cont. Ops) | $0.66 | $0.87 | -$0.04 | $1.22 | $1.24 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.87 | -$0.04 | $1.22 | $1.24 | |
Weighted Average Basic Share | $296.4M | $282.1M | $263.1M | $256.9M | $246.7M | |
Weighted Average Diluted Share | $297.7M | $282.6M | $263.1M | $257.6M | $247.2M | |
EBITDA | $705.1M | $806.3M | $475.1M | $949.3M | $962.4M | |
EBIT | $279.5M | $377.7M | $67.9M | $488.2M | $510.3M | |
Revenue (Reported) | $2B | $2.2B | $2.3B | $2.4B | $2.4B | |
Operating Income (Reported) | $275.3M | $375.9M | $301.6M | $452.3M | $466.9M | |
Operating Income (Adjusted) | $279.5M | $377.7M | $67.9M | $488.2M | $510.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $7.5B | $8.7B | $9.1B | $9.8B | $10.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.6B | $3.8B | $3.8B | $3.7B | $3.8B | |
Gross Profit | $3.9B | $4.9B | $5.3B | $6.1B | $6.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.9B | $3.4B | $3.7B | $4.1B | $4.3B | |
Other Inc / (Exp) | -- | -- | -$1.3B | $108.1M | $277.1M | |
Operating Expenses | $2.9B | $3.4B | $3.7B | $4.1B | $4.3B | |
Operating Income | $925.2M | $1.5B | $1.6B | $2B | $2.1B | |
Net Interest Expenses | $288.8M | $327M | $436M | $560.9M | $456.3M | |
EBT. Incl. Unusual Items | $636.5M | $1.1B | -$115.1M | $1.6B | $1.9B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $82.3M | $200.6M | $83.1M | $259.8M | $334.4M | |
Net Income to Company | $652.9M | $1B | -$110.7M | $1.4B | $1.6B | |
Minority Interest in Earnings | -$15.3M | -$25.6M | -$33.5M | -$45.7M | -$71.1M | |
Net Income to Common Excl Extra Items | $637.6M | $1B | -$144.3M | $1.3B | $1.6B | |
Basic EPS (Cont. Ops) | $2.13 | $3.50 | -$0.46 | $5.05 | $6.21 | |
Diluted EPS (Cont. Ops) | $2.13 | $3.49 | -$0.47 | $5.04 | $6.20 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2.6B | $3.2B | $2B | $4.1B | $4.4B | |
EBIT | $970.5M | $1.5B | $364M | $2.3B | $2.5B | |
Revenue (Reported) | $7.5B | $8.7B | $9.1B | $9.8B | $10.1B | |
Operating Income (Reported) | $925.2M | $1.5B | $1.6B | $2B | $2.1B | |
Operating Income (Adjusted) | $970.5M | $1.5B | $364M | $2.3B | $2.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2B | $2.2B | $2.3B | $2.4B | $2.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $925.2M | $957.2M | $947.8M | $922.4M | $921.2M | |
Gross Profit | $1.1B | $1.2B | $1.3B | $1.5B | $1.5B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $789.5M | $823.1M | $1B | $1B | $1B | |
Other Inc / (Exp) | -- | -- | -$244.8M | -- | $4M | |
Operating Expenses | $789.5M | $823.1M | $1B | $1B | $1B | |
Operating Income | $275.3M | $375.9M | $301.6M | $452.3M | $466.9M | |
Net Interest Expenses | $78.9M | $91.6M | $111.8M | $126.2M | $117.7M | |
EBT. Incl. Unusual Items | $196.4M | $284.4M | -$55.1M | $326M | $353.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $20.7M | $52.2M | -$31.4M | $19.4M | $58.7M | |
Net Income to Company | $198.4M | $249.6M | -$4.4M | $323.1M | $312.8M | |
Minority Interest in Earnings | -$1.7M | -$4.9M | -$6.6M | -$9.8M | -$7M | |
Net Income to Common Excl Extra Items | $196.7M | $244.7M | -$11M | $313.3M | $305.7M | |
Basic EPS (Cont. Ops) | $0.66 | $0.87 | -$0.04 | $1.22 | $1.24 | |
Diluted EPS (Cont. Ops) | $0.66 | $0.87 | -$0.04 | $1.22 | $1.24 | |
Weighted Average Basic Share | $296.4M | $282.1M | $263.1M | $256.9M | $246.7M | |
Weighted Average Diluted Share | $297.7M | $282.6M | $263.1M | $257.6M | $247.2M | |
EBITDA | $705.1M | $806.3M | $475.1M | $949.3M | $962.4M | |
EBIT | $279.5M | $377.7M | $67.9M | $488.2M | $510.3M | |
Revenue (Reported) | $2B | $2.2B | $2.3B | $2.4B | $2.4B | |
Operating Income (Reported) | $275.3M | $375.9M | $301.6M | $452.3M | $466.9M | |
Operating Income (Adjusted) | $279.5M | $377.7M | $67.9M | $488.2M | $510.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.9B | $2B | $2B | $2.1B | $2.5B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $794.2M | $946.2M | $998.3M | $1.1B | $1.1B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.9B | $1.8B | $3.2B | $4.9B | $2.4B | |
Total Current Assets | $4.6B | $4.7B | $6.3B | $8.1B | $6B | |
Property Plant And Equipment | $1.6B | $1.7B | $1.8B | $2.2B | $2.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $23.9B | $24.8B | $23.3B | $26.7B | $26.3B | |
Other Intangibles | $12B | $11.6B | $9.7B | $10.2B | $8.9B | |
Other Long-Term Assets | $2.1B | $2.4B | $3.6B | $2.6B | $2.5B | |
Total Assets | $44.2B | $45.3B | $44.8B | $50.6B | $46.9B | |
Accounts Payable | $128.7M | $262M | $229.4M | $290.4M | $320.1M | |
Accrued Expenses | $756.2M | $839.6M | $824.7M | $930.1M | $979.5M | |
Current Portion Of Long-Term Debt | $827.4M | $78.5M | $1.2B | $620.6M | $1.1B | |
Current Portion Of Capital Lease Obligations | $103.7M | $103.6M | $80.2M | $81.7M | $71.6M | |
Other Current Liabilities | $1.3B | $1.4B | $2.5B | $3.7B | $1.6B | |
Total Current Liabilities | $4.5B | $4.5B | $6.9B | $8.1B | $6.3B | |
Long-Term Debt | $8.5B | $11.4B | $12.3B | $15.7B | $15.2B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16.7B | $19.4B | $22.3B | $26.8B | $23.9B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$202.3M | -$234.2M | -$406M | -$258.9M | -$613M | |
Common Equity | $27.3B | $25.6B | $22.3B | $23B | $22.3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $154.7M | $241.2M | $236.7M | $788.3M | $735.9M | |
Total Equity | $27.5B | $25.9B | $22.5B | $23.8B | $23B | |
Total Liabilities and Equity | $44.2B | $45.3B | $44.8B | $50.6B | $46.9B | |
Cash and Short Terms | $1.9B | $2B | $2B | $2.1B | $2.5B | |
Total Debt | $9.7B | $12B | $14.2B | $17.3B | $16.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.1B | $2B | $2B | $2.2B | $2.9B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $824.8M | $973M | $1.1B | $1.1B | $1.1B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $2B | $2.1B | $2.4B | $6.4B | $2.7B | |
Total Current Assets | $4.9B | $5.2B | $5.6B | $9.7B | $6.7B | |
Property Plant And Equipment | $1.6B | $1.7B | $2B | $2.2B | $2.4B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $23.9B | $24.8B | $26.9B | $26.7B | $26.4B | |
Other Intangibles | $11.7B | $11.3B | $10.6B | $9.8B | $8.7B | |
Other Long-Term Assets | $2.2B | $2.5B | $3.5B | $2.6B | $2.5B | |
Total Assets | $44.3B | $45.4B | $48.6B | $51.8B | $47.6B | |
Accounts Payable | $2.1B | -- | -- | -- | $2.9B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $64.5M | $120.2M | $1.2B | $1.6B | $1.2B | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.5B | $1.7B | $1.9B | $5.2B | $2.3B | |
Total Current Liabilities | $4.1B | $4.9B | $6.1B | $10.5B | $7.1B | |
Long-Term Debt | $9.6B | $11.7B | $16.5B | $15.6B | $15B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $17.4B | $20B | $25.8B | $28.8B | $24.6B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -$212.4M | -$247.2M | -$410.8M | -$297.4M | -$449.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $150.4M | $235.2M | $799.6M | $770.3M | $776.2M | |
Total Equity | $26.8B | $25.4B | $22.9B | $23B | $23B | |
Total Liabilities and Equity | $44.3B | $45.4B | $48.6B | $51.8B | $47.6B | |
Cash and Short Terms | $2.1B | $2B | $2B | $2.2B | $2.9B | |
Total Debt | $10.2B | $12.3B | $18.2B | $18.2B | $16.9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $605.1M | $987.9M | $143.3M | $1B | $1.6B | |
Depreciation & Amoritzation | $1.6B | $1.7B | $1.7B | $1.8B | $1.9B | |
Stock-Based Compensation | $148.8M | $180.8M | $163.3M | $209M | $164.2M | |
Change in Accounts Receivable | $56M | -$165.5M | -$112M | -$78.6M | -$10.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2.3B | $2.8B | $2.2B | $2.2B | $3.5B | |
Capital Expenditures | $436.2M | $493.2M | $615.7M | $658.1M | $674.9M | |
Cash Acquisitions | -$160.8M | -$1.8B | -$95.4M | -$3.7B | $475.4M | |
Cash From Investing | -$438.3M | -$2.3B | -$675.5M | -$4.4B | -$173.9M | |
Dividends Paid (Ex Special Dividend) | -$233.2M | -$259.7M | -$274M | -$260.4M | -$252.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.4B | $7.2B | $9.8B | $10.3B | $9.6B | |
Long-Term Debt Repaid | -$2.3B | -$4.8B | -$7.9B | -$9.1B | -$8.3B | |
Repurchase of Common Stock | -$631.1M | -$2.6B | -$3B | -$459.5M | -$1.6B | |
Other Financing Activities | -$612.5M | $48.7M | -$389.8M | -$24.7M | -$438.5M | |
Cash From Financing | -$1.5B | -$405.4M | -$1.4B | $2.1B | -$2.8B | |
Beginning Cash (CF) | $1.7B | $2.1B | $2.1B | $2.2B | $2.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $329.7M | $81.6M | $191.8M | $28.8M | $591.9M | |
Ending Cash (CF) | $2.1B | $2.1B | $2.2B | $2.3B | $2.7B | |
Levered Free Cash Flow | $1.9B | $2.3B | $1.6B | $1.6B | $2.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $198.4M | $249.6M | -$4.4M | $323.1M | $312.8M | |
Depreciation & Amoritzation | $425.6M | $428.7M | $407.3M | $461.1M | $452.1M | |
Stock-Based Compensation | $37.2M | $38.4M | $89.6M | $40.1M | $39.7M | |
Change in Accounts Receivable | -$37.1M | -$34.2M | $30.8M | $50.9M | -$36.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $599.4M | $630M | $599.5M | $529.6M | $555.1M | |
Capital Expenditures | $86.2M | $156.1M | $162.2M | $145.4M | $127.6M | |
Cash Acquisitions | -$11.1M | -$4.7M | -$4B | -$2.6M | -$49.9M | |
Cash From Investing | -$96.9M | -$160.8M | -$4.2B | -$148M | -$173.1M | |
Dividends Paid (Ex Special Dividend) | -$57.6M | -$70.2M | -$65.8M | -$63.6M | -$61.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.1B | $1.5B | $4.7B | $4.7B | $1.8B | |
Long-Term Debt Repaid | -$1.6B | -$1.2B | -$1.8B | -$2.6B | -$2.5B | |
Repurchase of Common Stock | -$803M | -$649.7M | -$202.8M | -$800M | -$446.3M | |
Other Financing Activities | -$6.8M | -$7.2M | -$17.8M | -$403.6M | $410.4M | |
Cash From Financing | -$369M | -$376.3M | $3.6B | -$276.7M | -$31.5M | |
Beginning Cash (CF) | $2.1B | $2.1B | $2.2B | $2.3B | $2.7B | |
Foreign Exchange Rate Adjustment | -$21.1M | -$36.1M | $18.6M | -$34M | $61.8M | |
Additions / Reductions | $133.4M | $92.8M | $3.6M | $104.9M | $350.5M | |
Ending Cash (CF) | $2.2B | $2.2B | $2.2B | $2.3B | $3.1B | |
Levered Free Cash Flow | $513.2M | $473.9M | $437.3M | $384.1M | $427.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $652.9M | $1B | -$110.7M | $1.4B | $1.6B | |
Depreciation & Amoritzation | $1.6B | $1.7B | $1.6B | $1.8B | $1.9B | |
Stock-Based Compensation | $158.1M | $182M | $214.4M | $159.5M | $163.9M | |
Change in Accounts Receivable | -$28.8M | -$162.6M | -$47M | -$58.5M | -$98.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $2.5B | $2.8B | $2.2B | $2.2B | $3.6B | |
Capital Expenditures | $417.6M | $563.2M | $621.7M | $641.4M | $657.1M | |
Cash Acquisitions | -$104.7M | -$1.8B | -$4.1B | $297.7M | $428.1M | |
Cash From Investing | -$365.6M | -$2.4B | -$4.7B | -$302.3M | -$199M | |
Dividends Paid (Ex Special Dividend) | -$232.5M | -$272.4M | -$269.5M | -$258.3M | -$250.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $3.9B | $6.6B | $13B | $10.4B | $6.7B | |
Long-Term Debt Repaid | -$3.7B | -$4.4B | -$8.6B | -$9.9B | -$8.3B | |
Repurchase of Common Stock | -$1B | -$2.5B | -$2.5B | -$1.1B | -$1.3B | |
Other Financing Activities | -$619.3M | $48.2M | -$400.3M | -$410.5M | $375.4M | |
Cash From Financing | -$1.8B | -$412.7M | $2.6B | -$1.7B | -$2.5B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $273.7M | $41M | $102.5M | $130.1M | $837.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $2.1B | $2.2B | $1.6B | $1.5B | $2.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $198.4M | $249.6M | -$4.4M | $323.1M | $312.8M | |
Depreciation & Amoritzation | $425.6M | $428.7M | $407.3M | $461.1M | $452.1M | |
Stock-Based Compensation | $37.2M | $38.4M | $89.6M | $40.1M | $39.7M | |
Change in Accounts Receivable | -$37.1M | -$34.2M | $30.8M | $50.9M | -$36.7M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $599.4M | $630M | $599.5M | $529.6M | $555.1M | |
Capital Expenditures | $86.2M | $156.1M | $162.2M | $145.4M | $127.6M | |
Cash Acquisitions | -$11.1M | -$4.7M | -$4B | -$2.6M | -$49.9M | |
Cash From Investing | -$96.9M | -$160.8M | -$4.2B | -$148M | -$173.1M | |
Dividends Paid (Ex Special Dividend) | -$57.6M | -$70.2M | -$65.8M | -$63.6M | -$61.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.1B | $1.5B | $4.7B | $4.7B | $1.8B | |
Long-Term Debt Repaid | -$1.6B | -$1.2B | -$1.8B | -$2.6B | -$2.5B | |
Repurchase of Common Stock | -$803M | -$649.7M | -$202.8M | -$800M | -$446.3M | |
Other Financing Activities | -$6.8M | -$7.2M | -$17.8M | -$403.6M | $410.4M | |
Cash From Financing | -$369M | -$376.3M | $3.6B | -$276.7M | -$31.5M | |
Beginning Cash (CF) | $2.1B | $2.1B | $2.2B | $2.3B | $2.7B | |
Foreign Exchange Rate Adjustment | -$21.1M | -$36.1M | $18.6M | -$34M | $61.8M | |
Additions / Reductions | $133.4M | $92.8M | $3.6M | $104.9M | $350.5M | |
Ending Cash (CF) | $2.2B | $2.2B | $2.2B | $2.3B | $3.1B | |
Levered Free Cash Flow | $513.2M | $473.9M | $437.3M | $384.1M | $427.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.